United Therapeutics Corp UTHR:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/12/22 EDT
217.10quote price arrow down-3.31 (-1.50%)
Volume
484,600
52 week range
158.38 - 245.48
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close217.10
  • 52 Week High245.48
  • 52 Week High Date07/08/22
  • 52 Week Low158.38
  • 52 Week Low Date03/11/22

Key Stats

  • Market Cap9.882B
  • Shares Out45.52M
  • 10 Day Average Volume0.39M
  • Dividend-
  • Dividend Yield-
  • Beta0.53
  • YTD % Change0.47

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close217.10
  • 52 Week High245.48
  • 52 Week High Date07/08/22
  • 52 Week Low158.38
  • 52 Week Low Date03/11/22
  • Market Cap9.882B
  • Shares Out45.52M
  • 10 Day Average Volume0.39M
  • Dividend-
  • Dividend Yield-
  • Beta0.53
  • YTD % Change0.47

RATIOS/PROFITABILITY

  • EPS (TTM)13.20
  • P/E (TTM)16.45
  • Fwd P/E (NTM)13.41
  • EBITDA (TTM)940.70M
  • ROE (TTM)15.85%
  • Revenue (TTM)1.789B
  • Gross Margin (TTM)93.41%
  • Net Margin (TTM)35.27%
  • Debt To Equity (MRQ)18.53%

EVENTS

  • Earnings Date11/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On United Therapeutics Corp

There is no recent news for this security.

Profile

MORE
United Therapeutics Corporation is a pharmaceutical company. The Company markets and sells four commercial therapies in the United States to treat ulmonary arterial hypertension (PAH): Tyvaso (treprostinil) Inhalation Solution (Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso has also been approved to treat...
Martine Rothblatt J.D., Ph.D.
Chairman of the Board, Chief Executive Officer
Michael Benkowitz
President, Chief Operating Officer
James Edgemond
Chief Financial Officer, Treasurer
Paul Mahon J.D.
Executive Vice President, General Counsel, Corporate Secretary
Address
1040 SPRING ST
Silver Spring, MD
20910
United States

Top Peers

SYMBOLLASTCHG%CHG
RDY
Dr Reddy's Laboratories Ltd
53.64+0.52+0.98%
IONS
Ionis Pharmaceuticals Inc
44.10+0.66+1.52%
ELAN
Elanco Animal Health Inc
20.08+0.51+2.61%
BMRN
Biomarin Pharmaceutical Inc
95.07UNCHUNCH
EBS
Emergent BioSolutions Inc
30.50+0.61+2.04%